🇺🇸 FDA
Patent

US 7026484

Tricyclic androgen receptor modulator compounds and methods

expired A61PA61P1/14A61P13/08

Quick answer

US patent 7026484 (Tricyclic androgen receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
61
CPC classes
A61P, A61P1/14, A61P13/08, A61P15/00, A61P15/08